LFWD vs. ZYXI, RBOT, PETV, ECOR, MODD, MLSS, DRIO, POCI, COCH, and STRR
Should you be buying Lifeward stock or one of its competitors? The main competitors of Lifeward include Zynex (ZYXI), Vicarious Surgical (RBOT), PetVivo (PETV), electroCore (ECOR), Modular Medical (MODD), Milestone Scientific (MLSS), DarioHealth (DRIO), Precision Optics (POCI), Envoy Medical (COCH), and Star Equity (STRR). These companies are all part of the "medical equipment" industry.
Lifeward vs. Its Competitors
Lifeward (NASDAQ:LFWD) and Zynex (NASDAQ:ZYXI) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.
Lifeward has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Comparatively, Zynex has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.
Zynex has higher revenue and earnings than Lifeward. Zynex is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.
26.8% of Lifeward shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 2.7% of Lifeward shares are held by insiders. Comparatively, 49.3% of Zynex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Zynex had 2 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for Zynex and 1 mentions for Lifeward. Lifeward's average media sentiment score of 0.64 beat Zynex's score of 0.58 indicating that Lifeward is being referred to more favorably in the media.
Lifeward currently has a consensus target price of $9.00, suggesting a potential upside of 1,167.43%. Zynex has a consensus target price of $4.90, suggesting a potential upside of 265.67%. Given Lifeward's stronger consensus rating and higher probable upside, equities research analysts clearly believe Lifeward is more favorable than Zynex.
Zynex has a net margin of -19.79% compared to Lifeward's net margin of -121.80%. Zynex's return on equity of -78.54% beat Lifeward's return on equity.
Summary
Zynex beats Lifeward on 10 of the 16 factors compared between the two stocks.
Get Lifeward News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Lifeward Competitors List
Related Companies and Tools
This page (NASDAQ:LFWD) was last updated on 10/16/2025 by MarketBeat.com Staff